Literature DB >> 25192771

Greater reductions in nicotine exposure while smoking very low nicotine content cigarettes predict smoking cessation.

Sarah S Dermody1, Eric C Donny1, Louise A Hertsgaard2, Dorothy K Hatsukami3.   

Abstract

OBJECTIVE: Reducing the nicotine content of cigarettes is a potential regulatory strategy that may enable cessation. The present study investigated the effect of nicotine exposure while smoking very low nicotine content (VLNC) cigarettes on cessation outcomes. The roles of possible sources of nicotine were also explored, including the VLNC cigarette and co-use of cigarettes with normal nicotine content.
METHODS: A secondary data analysis of two analogous randomised trials of treatment seeking, adult daily smokers (n=112) who were instructed to smoke VLNC cigarettes for 6 weeks and then make a quit attempt. Controlling for baseline demographic and smoking features, the association between reductions in nicotine exposure during the 6-week trial, assessed by urinary total cotinine and biomarker-confirmed smoking abstinence 1 month later, was tested. Subsequent analyses controlled for the effects of the frequency of VLNC and normal nicotine content cigarette use and the nicotine yield of the VLNC cigarette (0.05 vs 0.09 mg).
RESULTS: Greater reductions in nicotine exposure while smoking VLNC cigarettes predicted abstinence independent of individual differences in baseline smoking, cotinine, dependence, gender and study. Nicotine reduction was largest among individuals who were assigned to smoke a VLNC cigarette with lower nicotine yield and who smoked fewer normal nicotine content and VLNC cigarettes.
CONCLUSIONS: In the context of nicotine regulations and corresponding research, factors that undermine nicotine reduction must be addressed, including the availability and use of cigarettes with normal nicotine content and not sufficiently reducing the nicotine yield of cigarettes. Maximising nicotine reduction may facilitate smoking cessation. TRIAL REGISTRATION NUMBERS: NCT 01050569 and NCT 00777569. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Cessation; Cotinine; Nicotine; Public policy

Mesh:

Substances:

Year:  2014        PMID: 25192771      PMCID: PMC4784094          DOI: 10.1136/tobaccocontrol-2014-051797

Source DB:  PubMed          Journal:  Tob Control        ISSN: 0964-4563            Impact factor:   7.552


  15 in total

1.  The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial.

Authors:  Natalie Walker; Colin Howe; Chris Bullen; Michele Grigg; Marewa Glover; Hayden McRobbie; Murray Laugesen; Varsha Parag; Robyn Whittaker
Journal:  Addiction       Date:  2012-05-17       Impact factor: 6.526

Review 2.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

3.  Nicotine intake and dose response when smoking reduced-nicotine content cigarettes.

Authors:  Neal L Benowitz; Peyton Jacob; Brenda Herrera
Journal:  Clin Pharmacol Ther       Date:  2006-12       Impact factor: 6.875

4.  Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States.

Authors:  L T Kozlowski; N Y Mehta; C T Sweeney; S S Schwartz; G P Vogler; M J Jarvis; R J West
Journal:  Tob Control       Date:  1998       Impact factor: 7.552

5.  Establishing a nicotine threshold for addiction. The implications for tobacco regulation.

Authors:  N L Benowitz; J E Henningfield
Journal:  N Engl J Med       Date:  1994-07-14       Impact factor: 91.245

6.  Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes.

Authors:  August R Buchhalter; Michelle C Acosta; Sarah E Evans; Alison B Breland; Thomas Eissenberg
Journal:  Addiction       Date:  2005-04       Impact factor: 6.526

7.  Prolonged exposure to denicotinized cigarettes with or without transdermal nicotine.

Authors:  Eric C Donny; Melissa Jones
Journal:  Drug Alcohol Depend       Date:  2009-05-15       Impact factor: 4.492

8.  A randomized trial of nicotine replacement therapy in combination with reduced-nicotine cigarettes for smoking cessation.

Authors:  Karen M Becker; Jed E Rose; Anthony P Albino
Journal:  Nicotine Tob Res       Date:  2008-07       Impact factor: 4.244

Review 9.  Nicotine reduction: strategic research plan.

Authors:  Dorothy K Hatsukami; Neal L Benowitz; Eric Donny; Jack Henningfield; Mitch Zeller
Journal:  Nicotine Tob Res       Date:  2012-10-25       Impact factor: 4.244

10.  Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation.

Authors:  Dorothy K Hatsukami; Michael Kotlyar; Louise A Hertsgaard; Yan Zhang; Steven G Carmella; Joni A Jensen; Sharon S Allen; Peter G Shields; Sharon E Murphy; Irina Stepanov; Stephen S Hecht
Journal:  Addiction       Date:  2010-02       Impact factor: 6.526

View more
  15 in total

1.  Randomized Trial of Reduced-Nicotine Standards for Cigarettes.

Authors:  Eric C Donny; Rachel L Denlinger; Jennifer W Tidey; Joseph S Koopmeiners; Neal L Benowitz; Ryan G Vandrey; Mustafa al'Absi; Steven G Carmella; Paul M Cinciripini; Sarah S Dermody; David J Drobes; Stephen S Hecht; Joni Jensen; Tonya Lane; Chap T Le; F Joseph McClernon; Ivan D Montoya; Sharon E Murphy; Jason D Robinson; Maxine L Stitzer; Andrew A Strasser; Hilary Tindle; Dorothy K Hatsukami
Journal:  N Engl J Med       Date:  2015-10       Impact factor: 91.245

2.  Nicotine and addiction beliefs and perceptions among the US-born and foreign-born populations.

Authors:  Anh B Nguyen; Xiaoquan Zhao; Leah Hoffman; Aura Lee Morse; Janine Delahanty
Journal:  Prev Med       Date:  2018-06-26       Impact factor: 4.018

3.  U.S. adults' addiction and harm beliefs about nicotine and low nicotine cigarettes.

Authors:  Erin Keely O'Brien; Anh B Nguyen; Alexander Persoskie; Allison C Hoffman
Journal:  Prev Med       Date:  2016-12-27       Impact factor: 4.018

4.  Differences in acute reinforcement across reduced nicotine content cigarettes.

Authors:  Kenneth A Perkins; Joshua L Karelitz
Journal:  Psychopharmacology (Berl)       Date:  2020-03-27       Impact factor: 4.530

5.  Low Nicotine Content Descriptors Reduce Perceived Health Risks and Positive Cigarette Ratings in Participants Using Very Low Nicotine Content Cigarettes.

Authors:  Rachel L Denlinger-Apte; Danielle L Joel; Andrew A Strasser; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2017-10-01       Impact factor: 4.244

6.  One-Year Smoking Trajectories Among Established Adult Smokers With Low Baseline Motivation to Quit.

Authors:  Amanda R Mathew; Elizabeth Garrett-Mayer; Bryan W Heckman; Amy E Wahlquist; Matthew J Carpenter
Journal:  Nicotine Tob Res       Date:  2017-12-13       Impact factor: 4.244

7.  Nicotine and Anatabine Exposure from Very Low Nicotine Content Cigarettes.

Authors:  Rachel L Denlinger; Tracy T Smith; Sharon E Murphy; Joseph S Koopmeiners; Neal L Benowitz; Dorothy K Hatsukami; Lauren R Pacek; Cirielle Colino; Samantha N Cwalina; Eric C Donny
Journal:  Tob Regul Sci       Date:  2016-04

8.  Regulatory Approaches and Implementation of Minimally Addictive Combusted Products.

Authors:  Dorothy K Hatsukami; Dongqun Xu; Geoffrey Ferris Wayne
Journal:  Nicotine Tob Res       Date:  2022-03-01       Impact factor: 5.825

Review 9.  The tobacco endgame: a qualitative review and synthesis.

Authors:  Patricia A McDaniel; Elizabeth A Smith; Ruth E Malone
Journal:  Tob Control       Date:  2015-08-28       Impact factor: 7.552

10.  Nicotine Reduction in Cigarettes: Literature Review and Gap Analysis.

Authors:  Micah L Berman; Allison M Glasser
Journal:  Nicotine Tob Res       Date:  2019-12-23       Impact factor: 4.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.